Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
5(25%)
Results Posted
0%(0 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
8
40%
Ph phase_2
2
10%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

5

trials recruiting

Total Trials

20

all time

Status Distribution
Active(6)
Completed(6)
Terminated(1)
Other(7)

Detailed Status

unknown6
Completed6
Recruiting5
Not yet recruiting1
Terminated1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
5
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (20.0%)
N/A8 (80.0%)

Trials by Status

unknown630%
not_yet_recruiting15%
terminated15%
completed630%
recruiting525%
suspended15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT04442061Phase 2

Autism Spectrum Disorders: Double Blind Randomized Placebo-control Active Pilot Study of Transcranial Magnetic Stimulation Applied to the Superior Temporal Sulcus

Completed
NCT05061953

Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis

Recruiting
NCT05661266

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Completed
NCT06256731

ETNA-MS Device Validation Study

Completed
NCT06283524

Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

Completed
NCT02165410Not Applicable

MRI Study of Cerebral Blood Flow in Development Disorders in Children

Completed
NCT07377227Not Applicable

Social COgnition Screening

Not Yet Recruiting
NCT06334588Not Applicable

Understanding the Mechanisms of Autism : an MRI and Social Cognition Study

Recruiting
NCT06058897Not Applicable

Magnetic Resonance Imaging (MRI) and Eye-tracking Predictive Markers of Cognitive Ageing.

Recruiting
NCT05186077

Brain Circuitry Analysis in Bipolar Disorder

Terminated
NCT06891612Not Applicable

Electroencephalographic Study of the Mechanisms of Inhibition of Emotional Memories in Young Healthy Subjects

Completed
NCT07110493Not Applicable

Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements

Recruiting
NCT05212727

Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Suspended
NCT05176704

Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease

Recruiting
NCT05277740

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

Unknown
NCT05186948

Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

Unknown
NCT04649892Phase 2

Predicting Response to Naltrexone With Eye Tracking in Videogame Disorder

Unknown
NCT03711045

An Eye Tracking Study of Affective Disorder Patients With Suicide Risk

Unknown
NCT03474796Not Applicable

Clinical Observation During Anaesthetic Induction: Which Difference Between Novice and Expert ?

Unknown
NCT02563418Not Applicable

Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study

Unknown

All 20 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
20